H43.2
Crystalline deposits in vitreous body
Clinical Classification Guidelines
Medical Intelligence & Overview
Crystalline deposits in the vitreous body occur when tiny mineral particles or other substances form cloud-like structures within the eye's vitreous humor. The vitreous body, a gel-like substance filling the space between the lens and the retina, plays a vital role in maintaining the eye's shape and transmitting light. When deposits develop, they can cause visual disturbances or be detected during eye examinations. While they are often benign, understanding their causes, symptoms, and potential impacts is important for eye health.
Causes & Symptoms
Clinical Causes: Age-related changes: As people age, natural degeneration can lead to the formation of crystalline deposits. Posterior vitreous detachment: The separation of the vitreous gel from the retina sometimes results in debris or deposits. Myriad eye conditions: Conditions such as diabetic retinopathy or retinal tears may contribute to deposit formation. Inflammation or infection: Eye inflammations can alter the vitreous structure, leading to deposits. Eye trauma: Physical injuries can disturb the vitreous composition, fostering deposit development. Metabolic disorders: Conditions affecting mineral metabolism, like hypercalcemia, might be linked to crystalline deposits.
Key Symptoms: Floaters: Small, shadowy spots or lines drifting across your field of vision. Visual clouding: A hazy or blurred appearance in parts of the visual field. No symptoms: Often, crystalline deposits are found during routine eye exams without causing noticeable symptoms. Photopsia: Flashes of light may occasionally accompany vitreous changes. Persistent visual disturbances: Especially if deposits are dense or numerous.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination, including dilated ophthalmoscopy, where an eye doctor inspects the vitreous and retina for deposits or other abnormalities. Additional imaging tests like optical coherence tomography (OCT) or ultrasound might be used to evaluate the vitreous and eye structures more closely. The absence of symptoms and the presence of deposits are often confirmed during routine check-ups or evaluation of floaters.
Treatment Protocols: Vitrectomy: A surgical procedure where the vitreous gel, along with the deposits, is removed and replaced with a saline solution. Laser therapy: In some instances, laser treatments can be used to break up or alter deposits, although this is not widely common for crystalline deposits specifically. Managing underlying conditions: Controlling systemic or ocular diseases that may contribute to deposit formation can help reduce new deposits.
Clinical Advice & FAQs
Billing Guidance
Is H43.2 a billable ICD-10 code?
Yes, H43.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H43.2?
Clinical documentation must specify the nature of Crystalline deposits in vitreous body and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
